Journal of the American Society of Nephrology, Vol 3, 1409-1415, Copyright © 1993 by American Society of Nephrology

REGULAR ARTICLES

Improvement of plasma lipoprotein profiles during high-flux dialysis

DS Seres, GW Strain, SA Hashim, IJ Goldberg and NW Levin
Department of Medicine, Beth Israel Medical Center, New York, NY.

Patients undergoing maintenance hemodialysis therapy have increased mortality due to cardiovascular disease. One possible etiologic factor for this increased mortality is the lipid abnormalities associated with chronic renal failure. These include elevated triglyceride (TG) and decreased high-density lipoprotein (HDL) concentrations. Lipoprotein profiles of patients undergoing chronic hemodialysis with either saponified cellulose ester (CE) (N = 9) or polysulfone (PS) high-flux dialysis membranes (N = 10) were compared. Patients in each group received similar amounts of heparin during the dialysis. CE-dialyzed patients showed no alteration in serum TG, HDL, low-density lipoprotein, or total cholesterol when predialysis and postdialysis values were compared. PS patients, on the other hand, had a significant decrease in TG concentrations (P < 0.01) as well as a significant rise in HDL (P < 0.01). These changes might signify activation of lipoprotein lipase (LPL) during dialysis. LPL activity in PS sera was significantly greater than LPL in CE sera. Moreover, sera from PS patients inhibited LPL much less than did sera from CE patients. These findings suggest that a circulating substance not dialyzable with cellulosic membranes inhibits LPL in uremic subjects and is removed during dialysis with a PS membrane. Alternatively, the greater biocompatibility of PS may produce less LPL inhibitory cytokines during dialysis. The improvement of lipoprotein profiles in patients receiving dialysis with PS membranes may, in the long term, lead to less morbidity and mortality from atherosclerotic disease.

This article has been cited by other articles:

				D. W. Mudge, R. Rogers, P. Hollett, B. Law, K. Reiger, J. J. B. Petrie, L. Price, D. W. Johnson, S. B. Campbell, N. M. Isbel, et al. Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance Nephrol. Dial. Transplant., October 1, 2005; 20(10): 2178 - 2185. [Abstract] [Full Text] [PDF]

				C. Wanner, U. Bahner, R. Mattern, D. Lang, and J. Passlick-Deetjen Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in haemodialysis patients Nephrol. Dial. Transplant., October 1, 2004; 19(10): 2570 - 2575. [Abstract] [Full Text] [PDF]

				A. K. Cheung, N. W. Levin, T. Greene, L. Agodoa, J. Bailey, G. Beck, W. Clark, A. S. Levey, J. K. Leypoldt, D. B. Ornt, et al. Effects of High-Flux Hemodialysis on Clinical Outcomes: Results of the HEMO Study J. Am. Soc. Nephrol., December 1, 2003; 14(12): 3251 - 3263. [Abstract] [Full Text] [PDF]

				F. Locatelli, F. Valderrabano, N. Hoenich, J. Bommer, K. Leunissen, and V. Cambi Progress in dialysis technology: membrane selection and patient outcome Nephrol. Dial. Transplant., August 1, 2000; 15(8): 1133 - 1139. [Full Text] [PDF]

				A. A. House, G. A. Wells, J. G. Donnelly, S. P. Nadler, and P. C. Hebert Randomized trial of high-flux vs low-flux haemodialysis: effects on homocysteine and lipids Nephrol. Dial. Transplant., July 1, 2000; 15(7): 1029 - 1034. [Abstract] [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673